Help your patients learn the importance of Raise, Regress, and Reduce.
Lipid disorders can be a daunting proposition for many patients. Depending on their specific CHD risk category, patients may be required to make sudden changes in diet, weight and daily activities, as well as remember to take one or more daily medications. Fortunately, a greater understanding of their disease and the simple steps that can be taken to reach HDL-C and other target goals can go a long way.
When it comes to reaching HDL-C and other targets, do your patients need extra support?
For your patients…related websites
Encourage your patients to learn more about cholesterol and lipid disorders with this at-a-glance guide to related websites.
Help your patients with therapy through the Heart Alliance program. Learn More »
Sign up to receive more information about NIASPAN and issues relevant to your practice.
NIASPAN is a prescription niacin agent indicated to RAISE HDL-C, REGRESS atherosclerosis, and REDUCE recurrent non-fatal MI.*
*In patients with a history of coronary artery disease and hypercholesterolemia, niacin, in combination with a bile acid binding resin, is indicated to slow progression or promote regression of atherosclerotic disease. In patients with a history of myocardial infarction and hypercholesterolemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction.
Next: NIASPAN Email Sign-Up
